Literature DB >> 10637138

Calmidazolium-induced rises in cytosolic calcium concentrations in Madin Darby canine kidney cells.

C R Jan1, C J Tseng.   

Abstract

The effect of calmidazolium on Ca(2+) signaling in Madin Darby canine kidney (MDCK) cells was investigated using fura-2 as a Ca(2+) probe. Calmidazolium at 2-5 microM increased [Ca(2+)](i) concentration dependently. The [Ca(2+)](i) rise induced by 2-5 microM calmidazolium comprised an immediate rise and a slow decay. External Ca(2+) removal partly inhibited the Ca(2+) signals, suggesting that calmidazolium activated external Ca(2+) influx and internal Ca(2+) release. In Ca(2+)-free medium, pretreatment with 3 microM calmidazolium abolished the Ca(2+) release induced by 1 microM thapsigargin, an endoplasmic reticulum Ca(2+) pump inhibitor, and, vice versa, pretreatment with thapsigargin inhibited calmidazolium-induced Ca(2+) release. This indicates that thapsigargin-sensitive Ca(2+) store was the source of calmidazolium-induced Ca(2+) release. Calmidazolium (3 microM) induced Mn(2+) quench of fura-2 fluorescence at 360 nm excitation wavelength, which was suppressed by 0.1 mM La(3+). Addition of 3 mM Ca(2+) increased [Ca(2+)](i) after pretreatment with 3-5 microM calmidazolium in Ca(2+)-free medium. This implies that calmidazolium activated concentration-dependent capacitative Ca(2+) entry. Calmidazolium (3 microM) augmented the capacitative Ca(2+) entry induced by 1 microM thapsigargin or 0.1 mM ATP by 38%. Calmidazolium (3 microM)-induced Ca(2+) release was blocked by pretreatment with 40 microM aristolochic acid and 2 microM U73122 (2 microM) to inhibit phospholipase A(2) and phospholipase, respectively, but pretreatment with 0.1 mM propranolol to inhibit phospholipase D had no effect. This suggests that calmidazolium induced internal Ca(2+) release in a manner dependent on phospholipases C- and A(2)-coupled events. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10637138     DOI: 10.1006/taap.1999.8844

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  6 in total

1.  Calmodulin kinase pathway mediates the K+-induced increase in Gap junctional communication between mouse spinal cord astrocytes.

Authors:  M H De Pina-Benabou; M Srinivas; D C Spray; E Scemes
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

2.  Calmidazolium and arachidonate activate a calcium entry pathway that is distinct from store-operated calcium influx in HeLa cells.

Authors:  Claire M Peppiatt; Anthony M Holmes; Jeong T Seo; Martin D Bootman; Tony J Collins; Fraser McDonald; H Llewelyn Roderick
Journal:  Biochem J       Date:  2004-08-01       Impact factor: 3.857

3.  Inhibition of nitric oxide-activated guanylyl cyclase by calmodulin antagonists.

Authors:  L R James; C H Griffiths; J Garthwaite; T C Bellamy
Journal:  Br J Pharmacol       Date:  2009-10-20       Impact factor: 8.739

4.  Attenuation of calmodulin regulation evokes Ca2+ oscillations: evidence for the involvement of intracellular arachidonate-activated channels and connexons.

Authors:  Egor A Turovsky; Valery P Zinchenko; Nikolai P Kaimachnikov
Journal:  Mol Cell Biochem       Date:  2019-02-11       Impact factor: 3.396

5.  Possible Involvement of 2',3'-Cyclic Nucleotide-3'-Phosphodiesterase in the Protein Phosphorylation-Mediated Regulation of the Permeability Transition Pore.

Authors:  Yulia Baburina; Irina Odinokova; Tamara Azarashvili; Vladimir Akatov; Linda Sotnikova; Olga Krestinina
Journal:  Int J Mol Sci       Date:  2018-11-07       Impact factor: 5.923

6.  Down Regulation of Catsper1 Expression by Calmodulin Inhibitor (Calmidazolium): Possible Implications for Fertility.

Authors:  Angela Forero-Forero; Stephany López-Ramírez; Ricardo Felix; Javier Hernández-Sánchez; Emiliano Tesoro-Cruz; Sandra Orozco-Suárez; Janet Murbartián; Elizabeth Soria-Castro; Aleida Olivares; Carolina Bekker-Méndez; Vladimir Paredes-Cervantes; Norma Oviedo
Journal:  Int J Mol Sci       Date:  2022-07-22       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.